Yes, endocrinologists treat autoimmune disorders, but specifically the ones that attack hormone-producing glands. If your immune system is damaging your thyroid, pancreas, adrenal glands, or other parts of the endocrine system, an endocrinologist is typically the right specialist. They won’t, however, treat systemic autoimmune conditions like rheumatoid arthritis or lupus. Those fall under rheumatology.
The distinction comes down to organ-specific versus systemic autoimmune disease. Endocrinologists handle the organ-specific side when the target is a gland. Rheumatologists handle conditions where the immune system attacks joints, connective tissue, or multiple organ systems at once.
Autoimmune Conditions Endocrinologists Treat
The most common autoimmune conditions managed by endocrinologists involve the thyroid, pancreas, and adrenal glands. These include:
- Hashimoto’s thyroiditis: the leading cause of hypothyroidism, where immune cells gradually destroy thyroid tissue
- Graves’ disease: the most common cause of hyperthyroidism, driven by antibodies that overstimulate the thyroid
- Type 1 diabetes: where the immune system destroys insulin-producing cells in the pancreas
- Addison’s disease (autoimmune adrenalitis): the most common cause of primary adrenal insufficiency in developed countries, where antibodies attack the adrenal cortex
- Autoimmune primary ovarian insufficiency: a rare condition found in roughly 4 percent of women who experience premature ovarian failure before age 40
Women are disproportionately affected by autoimmune endocrine disorders. Global data shows women have nearly double the prevalence rate of endocrine, metabolic, and immune disorders compared to men, with the highest rates among women aged 65 to 69.
How Endocrinologists Diagnose Autoimmune Gland Disease
Endocrinologists use a two-step process: first confirm that a gland isn’t working properly, then determine whether autoimmunity is the cause. They do this primarily through blood tests that measure both hormone levels and specific antibodies your immune system produces against your own tissues.
For Graves’ disease, the key marker is TSH receptor antibodies, which have a sensitivity and specificity around 95 percent. The classic blood work pattern shows a suppressed TSH (the signal your brain sends to the thyroid) alongside elevated thyroid hormones and positive receptor antibodies. For Hashimoto’s, endocrinologists look for antibodies against thyroid peroxidase (anti-TPO), an enzyme the thyroid uses to make hormones.
Type 1 diabetes diagnosis relies on antibodies against insulin itself, against an enzyme called glutamic acid decarboxylase (GAD), and against a protein called IA-2. These markers can appear years before blood sugar levels become abnormal, which means at-risk individuals can sometimes be identified early.
Addison’s disease involves detecting adrenal cortex antibodies, found in 60 to 81 percent of patients with autoimmune adrenal failure. The major target these antibodies attack is an enzyme called 21-hydroxylase, which the adrenal glands need to produce cortisol. Imaging often shows small, non-calcified adrenal glands, which helps distinguish the autoimmune form from other causes like tuberculosis or tumors, where the glands tend to be enlarged or calcified.
Treatment Focuses on Replacing Hormones, Not Suppressing Immunity
Here’s something that surprises many patients: for most autoimmune endocrine conditions, the treatment isn’t aimed at calming the immune system. It’s aimed at replacing whatever hormone the damaged gland can no longer produce. Hormone replacement remains the standard approach. It manages symptoms effectively but doesn’t address the underlying immune attack.
In practical terms, this means levothyroxine tablets for Hashimoto’s, insulin injections for type 1 diabetes, and daily hydrocortisone (typically 15 to 25 mg split across two or three doses) for adrenal insufficiency. Graves’ disease is somewhat different because the gland is being overstimulated rather than destroyed, so treatment may involve medication to reduce thyroid hormone production, radioactive iodine, or surgery.
This hormone-replacement approach is why endocrinologists are the right specialists for these conditions. They’re experts in fine-tuning hormone doses, monitoring levels over time, and adjusting treatment as the disease progresses. A rheumatologist’s toolkit of immune-suppressing medications isn’t typically what’s needed.
When Multiple Glands Are Under Attack
About 60 percent of people with autoimmune Addison’s disease also have autoimmune problems in other glands. This clustering is called autoimmune polyglandular syndrome, and it comes in distinct patterns.
Type 1 polyglandular syndrome typically appears in childhood and is diagnosed when at least two of three features are present: chronic fungal infections of the skin and mucous membranes, underactive parathyroid glands (causing low calcium), and Addison’s disease. Type 2 involves the combination of type 1 diabetes, Addison’s disease, and autoimmune hypothyroidism. Type 3 looks like type 2 but without adrenal involvement.
Managing these syndromes means juggling multiple hormone replacements simultaneously and screening regularly for new gland failures that haven’t yet caused symptoms. Patients with type 1 polyglandular syndrome are best followed by an endocrinologist at an academic medical center, often with a multidisciplinary team. Even patients with a single autoimmune endocrine condition should expect periodic screening for related conditions, since having one autoimmune gland problem raises the risk of developing others. Rheumatologists, for instance, recognize that thyroid disease shows up more frequently in their patients with systemic autoimmune conditions.
Newer Autoimmune Endocrine Problems From Cancer Treatment
A growing area of endocrine autoimmunity involves immune checkpoint inhibitors, a class of cancer drugs that work by releasing the brakes on the immune system. The same unleashed immune response that fights cancer can also attack endocrine glands, causing inflammation of the pituitary gland, thyroid dysfunction, new-onset diabetes from destruction of insulin-producing cells, or adrenal problems.
European Society of Endocrinology guidelines recommend that patients who develop sustained or multiple endocrine problems from these drugs should have an endocrinologist involved in their ongoing care. The one exception is isolated hypothyroidism, which a primary care doctor or oncologist can manage with levothyroxine alone. Importantly, a controlled endocrine side effect is not a reason to stop cancer treatment. The endocrine condition is managed alongside continued therapy.
Which Specialist You Actually Need
If your primary care doctor has found abnormal thyroid antibodies, elevated blood sugar with suspected type 1 diabetes, or unexplained low cortisol, an endocrinologist is the appropriate referral. If your symptoms involve joint pain, skin rashes, widespread inflammation, or conditions like lupus or rheumatoid arthritis, you need a rheumatologist.
Some patients need both. Someone with lupus who also develops autoimmune thyroid disease may see a rheumatologist for the lupus and an endocrinologist for the thyroid. The two specialties share common ground because autoimmune diseases tend to cluster, but their treatment approaches are fundamentally different. Rheumatologists suppress immune activity. Endocrinologists replace what the immune system has destroyed.